Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Smiths Lueong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2776-6706; OpenAlex author ID A5000239454. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
38
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 2 papers

Papers 7

  1. Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell-free RNA. Last author DOI 10.1002/1878-0261.13747↗
  2. PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2025.115541↗
  3. Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription. Co-author DOI 10.1126/sciadv.adg5109↗
  4. Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression. Co-author DOI 10.1038/s41467-021-27088-9↗
  5. Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40170-022-00298-5↗
  6. Functional metabolic phenotyping of human pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2021.07.23.452145↗
  7. TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer. Last author DOI 10.1038/s41420-020-0246-7↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jens Thomas Siveke · 7 shared papers, 2020–2025 · strength 0.93
  2. Marija Trajkovic‐Arsic · 5 shared papers, 2020–2025 · strength 0.70
  3. Stephan A. Hahn · 5 shared papers, 2020–2025 · strength 0.63
  4. Phyllis F. Cheung · 5 shared papers, 2021–2025 · strength 0.63
  5. Hendrik Schürmann · 2 shared papers, 2025 · strength 0.40
  6. Laura Godfrey · 3 shared papers, 2021–2025 · strength 0.40
  7. Jörg D. Hoheisel · 3 shared papers, 2021–2025 · strength 0.40
  8. Andrea Tannapfel · 3 shared papers, 2021–2023 · strength 0.33
  9. Rui Fang · 2 shared papers, 2022–2025 · strength 0.30
  10. Ben Zhao · 2 shared papers, 2020–2025 · strength 0.30
  11. Erik H.J.G. Aarntzen · 3 shared papers, 2021–2022 · strength 0.30
  12. E. Smeets · 3 shared papers, 2021–2022 · strength 0.30
  13. Madeleine Dorsch · 1 shared paper, 2025 · strength 0.20
  14. Barbara M. Grüner · 1 shared paper, 2025 · strength 0.20
  15. Martin Metzenmacher · 1 shared paper, 2025 · strength 0.20
  16. Alexander Muckenhuber · 1 shared paper, 2025 · strength 0.20
  17. Volker Kunzmann · 1 shared paper, 2025 · strength 0.20
  18. Timm M. Reißig · 1 shared paper, 2025 · strength 0.20
  19. Grainne Mary O'Kane · 1 shared paper, 2025 · strength 0.20
  20. Jennifer Jane Knox · 1 shared paper, 2025 · strength 0.20
  21. Steve Gallinger · 1 shared paper, 2025 · strength 0.20
  22. Sven‐Thorsten Liffers · 2 shared papers, 2020–2022 · strength 0.20
  23. Waldemar H. Uhl · 2 shared papers, 2021–2022 · strength 0.20
  24. Irina Heid · 2 shared papers, 2021–2022 · strength 0.20
  25. Rickmer Braren · 2 shared papers, 2021–2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.